Departamento de Inmunología, Instituto de Investigaciones Biomédicas, Universidad Nacional Autónoma de México, C.P. 04510, Mexico City, Mexico.
Catedrática CONAHCYT, Departamento de Inmunología, Instituto de Investigaciones Biomédicas, Universidad Nacional Autónoma de México, C.P. 04510, Mexico City, Mexico.
Curr Microbiol. 2024 May 30;81(7):197. doi: 10.1007/s00284-024-03697-7.
Identifying and evaluating potential vaccine candidates has become one of the main objectives to combat tuberculosis. Among them, mannosylated Apa antigen from Mycobacterium tuberculosis and the non-mannosylated protein expressed in Escherichia coli, have been studied. Although both proteins can induce a protective response in mice, it has been considered that native protein can be dispensed. In this work, we study the protective response induced by Apa expressed in E. coli and in Streptomyces lividans. The latter, like native is secreted as a double band of 45/47 kDa, however, only its 47 kDa band is mannosylated. Both antigens and BCG were intranasal administrated in mice, and animals were then challenged by aerosol with M. tuberculosis H37Rv. The results showed that both, Apa from S. lividans and E. coli conferred statistically significantly protection to animals compared to controls. The cytokine immune response was studied by an immunoassay after animals' immunization, revealing that Apa from S. lividans induced a statistically significant proliferation of T cell, as well as the expression of IFN-γ, IL-1β, IL-17 and IL-10. In contrast, non-proliferation was obtained with non-mannosylated protein, but induction of IL-12 and IL-17 was observed. Together, these results demonstrate that both proteins were able to modulate a specific immune response against M. tuberculosis, that could be driven by different mechanisms possibly associated with the presence or not of mannosylation. Furthermore, stimulation of cells from BCG-vaccinated animals with the proteins could be an important tool, to help define the use of a given subunit-vaccine after BCG vaccination.
鉴定和评估潜在的疫苗候选物已成为对抗结核病的主要目标之一。其中,已研究了结核分枝杆菌的甘露糖化 Apa 抗原和大肠杆菌中表达的非甘露糖化蛋白。尽管这两种蛋白质都可以在小鼠中诱导保护性反应,但人们认为可以不用天然蛋白。在这项工作中,我们研究了在大肠杆菌和链霉菌中表达的 Apa 诱导的保护性反应。后者与天然蛋白一样,作为 45/47 kDa 的双带分泌,但只有其 47 kDa 带是甘露糖化的。两种抗原和卡介苗都通过鼻腔给药给小鼠,然后用结核分枝杆菌 H37Rv 气溶胶对动物进行攻击。结果表明,与对照组相比,来自 S. lividans 和 E. coli 的 Apa 都能使动物获得统计学上显著的保护。通过免疫测定研究了动物免疫后的细胞因子免疫反应,结果表明,来自 S. lividans 的 Apa 诱导了 T 细胞的统计学上显著增殖,以及 IFN-γ、IL-1β、IL-17 和 IL-10 的表达。相比之下,未甘露糖化的蛋白未引起增殖,但观察到了 IL-12 和 IL-17 的诱导。总之,这些结果表明,这两种蛋白都能够调节针对结核分枝杆菌的特异性免疫反应,这可能是由不同的机制驱动的,可能与甘露糖化的存在与否有关。此外,用这些蛋白刺激卡介苗接种动物的细胞可能是一个重要的工具,可以帮助确定在卡介苗接种后使用特定的亚单位疫苗。